Growth Metrics

Core Laboratories (CLB) Other Non-Current Liabilities (2022 - 2026)

Core Laboratories filings provide 5 years of Other Non-Current Liabilities readings, the most recent being $15.9 million for Q1 2026.

  • On a quarterly basis, Other Non-Current Liabilities fell 24.41% to $15.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was $15.9 million, a 24.41% decrease, with the full-year FY2025 number at $15.8 million, down 23.56% from a year prior.
  • Other Non-Current Liabilities hit $15.9 million in Q1 2026 for Core Laboratories, roughly flat from $15.8 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $21.9 million in Q2 2025 to a low of $15.8 million in Q4 2025.
  • Median Other Non-Current Liabilities over the past 5 years was $20.2 million (2024), compared with a mean of $19.7 million.
  • Biggest five-year swings in Other Non-Current Liabilities: rose 7.59% in 2024 and later fell 24.41% in 2026.
  • Core Laboratories' Other Non-Current Liabilities stood at $20.9 million in 2022, then decreased by 4.04% to $20.0 million in 2023, then increased by 3.45% to $20.7 million in 2024, then decreased by 23.56% to $15.8 million in 2025, then rose by 0.13% to $15.9 million in 2026.
  • The last three reported values for Other Non-Current Liabilities were $15.9 million (Q1 2026), $15.8 million (Q4 2025), and $21.4 million (Q3 2025) per Business Quant data.